Join
Live feed
·
INSIDERFilingvia Quantisnow
Axogen Inc. logo

Director Tyndall Joseph A. sold $173,940 worth of shares (3,500 units at $49.70) as part of a pre-agreed trading plan, decreasing direct ownership by 25% to 10,650 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AXGN· Axogen Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AXGN (Axogen Inc.) and more on Quantisnow.